David E. Levy

Q: What Schools Are Affiliated With David E. Levy

David E. Levy is affiliated with the following schools: University of Cincinnati, University of Michigan, Cornell University

David E. Levy's AcademicInfluence.com Rankings

David E. Levy

Philosophy

#11558

World Rank

#15936

Historical Rank

Logic

#8366

World Rank

#10461

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David E. Levy's Degrees

Bachelors Biology University of California, Berkeley
Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is David E. Levy Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David E. Levy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial (1996) (1081)
Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. (1983) (662)
Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes (1992) (569)
Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia (1982) (531)
Predicting outcome from hypoxic-ischemic coma. (1985) (376)
Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset (1992) (366)
Prognosis in nontraumatic coma. (1981) (352)
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. (2000) (285)
Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke (1994) (216)
Time of hospital presentation in patients with acute stroke. (1993) (195)
CEREBRAL ENERGY METABOLISM DURING TRANSIENT ISCHEMIA AND RECOVERY IN THE GERBIL 1 (1977) (193)
Differences in cerebral blood flow and glucose utilization in vegetative versus locked‐in patients (1987) (193)
PLATELET ACTIVATION IN ACUTE CEREBRAL ISCHÆMIA Serial Measurements of Platelet Function in Cerebrovascular Disease (1977) (183)
A prospective study of nontraumatic coma: Methods and results in 310 patients (1977) (169)
How transient are transient ischemic attacks? (1988) (151)
Delayed postischemic hypoperfusion (1979) (147)
Risk factors and clinical manifestations of pathologically verified lacunar infarctions. (1989) (145)
Regional Brain Blood Flow in the Conscious Gerbil (1978) (137)
Hypoxic‐ischemic brain injury and the vegetative state (1981) (119)
Urgent Therapy for Acute Stroke: Effects of a Stroke Trial on Untreated Patients (1994) (114)
Blood pressure during the first minutes of focal cerebral ischemia. (1993) (111)
Ischaemic brain damage in the gerbil in the absence of 'no-reflow'. (1975) (107)
Communications between vertebro-basilar and carotid arterial circulations in the gerbil. (1974) (96)
Experimental cerebral ischemia produces platelet aggregates (1979) (95)
Hyperfibrinogenemia and functional outcome from acute ischemic stroke. (2009) (93)
Selective chromatolysis of neurons in the gerbil brain: A possible consequence of “epileptic” activity produced by common carotid artery occlusion (1979) (86)
Ancrod in Acute Ischemic Stroke: Results of 500 Subjects Beginning Treatment Within 6 Hours of Stroke Onset in the Ancrod Stroke Program (2009) (84)
Brief hypoxia-ischemia initially damages cerebral neurons. (1975) (81)
THE VEGETATIVE STATE AND ITS PROGNOSIS FOLLOWING NONTRAUMATIC COMA * (1978) (78)
Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia. (1985) (74)
Delayed pentobarbital administration limits ischemic brain damage in gerbils (1979) (66)
Comparison of radio-labeled butanol and iodoantipyrine as cerebral blood flow markers (1981) (51)
Ischemic Brain Injury and the Therapeutic Window (1997) (47)
Prediction tree for severely head-injured patients. (1992) (42)
The importance of cerebral arterioles in alterations of the blood-brain barrier. (1980) (39)
Identification and entry of the patient with acute cerebral infarction. (1988) (39)
Cerebral blood flow in the four-vessel occlusion rat model. (1983) (38)
Effect of ischemia on energy metabolism in the gerbil cerebral cortex 1 (1975) (36)
Transient benign unilateral pupillary dilation in young adults. (1974) (34)
Ancrod and Fibrin Formation: Perspectives on Mechanisms of Action (2011) (32)
The investigational use of tPA for stroke. (1988) (32)
Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT). (2002) (31)
Experimental cerebral ischemia produced by extracranial vascular injury (1982) (28)
Clinical predictors of outcome in ischemic stroke. (1983) (28)
Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies. (2009) (22)
Predicting prognosis in coma. Can one improve medical decisions? (1978) (22)
Transient CNS deficits (1988) (22)
Outcome prediction in comatose patients: significance of reflex eye movement analysis. (1988) (21)
A mask for delivery of inhalation gases to small laboratory animals. (1980) (17)
Risk associated with heparin withdrawal in ischaemic cerebrovascular disease. (1989) (13)
Ancrod: A Potential Treatment for Acute, Ischemic Stroke from Snake Venom (2006) (13)
Relationship Between Ischemic Neuronal Damage and Edema in Primate and Rodent Brain (1976) (9)
Strategies for Early Treatment of Acute Cerebral Infarction (1991) (8)
Factors Related to Intracranial Hematoma Formation in Patients Receiving t-PA for Acute Ischemic Stroke (1993) (4)
Ethical Considerations in the Care of Unconscious Patients (1983) (4)
Outcome from severe neurological illness; should it influence medical decisions? (1979) (3)
Evaluation of Tissue Plasminogen Activator Early in the Course of Acute Ischemic Stroke (1991) (2)
Recovery from nontraumatic coma. (1978) (1)
Coma after cardiac arrest--how much care is enough? (1987) (1)
Discussion: Metabolic Aspects of Cerebral Hypoxia-Ischemia (1977) (1)
Reply (1988) (0)
Predicting the Outcome From Hypoxic-Ischemic Coma-Reply (1985) (0)
Outcome from severe neurological illness (2009) (0)
Ischaemic brain damage inthegerbil inthe absence of'no-reflow'1 (1975) (0)
Riskassociated withheparin withdrawal inischaemic cerebrovascular disease (1989) (0)
Outcome from severe neurological illness; should it influence medical decisions? (1979) (0)
Transient Benign Unilateral Pupillary Dilation-Reply (1975) (0)
Advances in neurology, vol 19: Neurological epidemiology: Principles and clinical applications. Edited by B. S. Schoenberg Raven Press, New York, 1978 672 pp, illustrated, $45.00 (1979) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David E. Levy?

David E. Levy is affiliated with the following schools:

David E. Levy's Academic­Influence.com Rankings